17.11.2022

Mariola Fotin-Mleczek, PhD, has joined Ardigen’s Scientific Board to support the drug discovery process for cancer immunology therapies

Read more
#

Ardigen's feed news

Mariola Fotin-Mleczek, PhD, has joined Ardigen’s Scientific Board to support the drug discovery process for cancer immunology therapies
17.11.2022
Mariola Fotin-Mleczek, PhD, has joined Ardigen’s Scientific Board to support the drug discovery process for cancer immunology therapies
Read more
Ardigen supports JUMP-CP Consortium scaling up image-based drug discovery with the world’s largest public Cell Painting dataset
27 October 2022
Ardigen supports JUMP-CP Consortium scaling up image-based drug discovery with the world’s largest public Cell Painting dataset
Read more
Agnieszka Blum, MD, PhD has been promoted to the Management Board of Ardigen to strengthen drug discovery expertise.
25 October 2022
Agnieszka Blum, MD, PhD has been promoted to the Management Board of Ardigen to strengthen drug discovery expertise.
Read more
Prof. Dr. med. Michael Schmitt, MHBA has joined Ardigen's Scientific Board to support the development of AI platforms for cell therapy discovery.
14 September 2022
Prof. Dr. med. Michael Schmitt, MHBA has joined Ardigen's Scientific Board to support the development of AI platforms for cell therapy discovery.
Read more
Łukasz Dutkiewicz, PhD has joined Ardigen as a Business Development Director
24 March 2022
Łukasz Dutkiewicz, PhD has joined Ardigen as a Business Development Director
Read more
Ardigen's Gene Regulation Platform
11 February 2022
Ardigen's Gene Regulation Platform
Boost your way to successful therapy. AI for Drug Discovery Days
28 January 2022
Boost your way to successful therapy. AI for Drug Discovery Days
Continue reading
Ardigen - new corporate identity
01 January 2022
Ardigen - new corporate identity
Continue reading
Merry Christmas 2021
24 December 2021
Merry Christmas 2021
Continue reading
Go up